OraSure Technologies's quarterly market cap
increased
from Sep. 2023 (€415.2 Mil) to Dec. 2023 (€547.8 Mil) but then
declined
from Dec. 2023 (€547.8 Mil) to Mar. 2024 (€417.9 Mil).
OraSure Technologies's annual market cap
declined
from Dec. 2021 (€554.4 Mil) to Dec. 2022 (€324.4 Mil) but then
increased
from Dec. 2022 (€324.4 Mil) to Dec. 2023 (€547.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OraSure Technologies's Enterprise Value for Today is €99.8 Mil.
OraSure Technologies Market Cap Historical Data
The historical data trend for OraSure Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OraSure Technologies's Market Cap
For the Medical Instruments & Supplies subindustry, OraSure Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's Market Cap falls into.
OraSure Technologies Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
OraSure Technologies's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies (FRA:EP3) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OraSure Technologies Market Cap Related Terms
Thank you for viewing the detailed overview of OraSure Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
OraSure Technologies (FRA:EP3) Business Description
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:EP3 has been successfully added to your 